Rik Kielman

Chief Executive Officer @ IMPLICAN B.V.

About

My team and I are on a mission to transform our innovative prototype into a leading market player dedicated to eliminating anastomotic leakage in colorectal surgery. Our groundbreaking solutions do not only enhance patient outcomes but also add significant value for hospitals, society, and our shareholders.In my previous role at Sensius, I played a pivotal role in defining and executing the commercial strategy, where I built a comprehensive list of clinics across Western Europe and the USA, effectively serving them through our network of agents. I defined a reimbursement strategy and translated it into clinical trials to provide the robust evidence needed for successful market entry. A feasibility trial is already ongoing in ErasmusMC, Rotterdam.At Implican, my current focus is on driving fundraising efforts to secure the necessary resources to execute our strategy. My role encompasses defining and executing a comprehensive go-to-market strategy that includes navigating regulatory access, orchestrating clinical trials, and establishing reimbursement pathways. Together with the Implican team, we aim to set new standards in the success of colorectal surgery.

Country

Netherlands

City

Greater Groningen Area

Industry

Medical Device

Skill

Hospital Reimbursement, Clinical Trials, New Product Rollout, Fundraising, Business-to-Business (B2B), Key Account Management, Business Strategy, B2B, Business Development, Sales Management, International Sales, Marketing Strategy, New Business Development, Product Development, Finance, Entrepreneurship, Management, Start-ups, Sales

Experience

Chief Executive Officer

IMPLICAN B.V.

2026-1 - Present · 8 mos

Greater Groningen Area

My major duty is to secure funding for the development and commercialisation of the Implican device. This entails the organisation of clinical trials, the regulatory pathway and the reimbursement trajectory, followed by the market introduction. This assignment is a perfect follow up of my previous commercial medtech roles (Gannet and Sensius) and combines my experience of selling medtech devices to hospitals and the preparation of that process (clinical trails and reimbursement).

CCO at Sensius

Sensius

2022-5 - 2026-1 · 3 yrs 9 mos

Rotterdam, South Holland, Netherlands

Responsible for Marketing & Sales

Director Marketing & Sales

Sensius

2020-1 - 2022-5 · 2 yrs 5 mos

Rotterdam, South Holland, Netherlands

Responsible for marketing strategy and execution. Reimbursement strategies. International sales of oncology medtech devices to hospitals.

Hospital introduction manager

Gannet B.V.

2013-4 - 2022-5 · 9 yrs 2 mos

Groningen

Gannet BV is a distribution company for the Gannet (an implant for femoral neck fractures). Since 2013 I have been involved in making the businessplan, acquiring venture capital and currently introducing the Gannet at hospitals in NW Europe, while involving health care reimbursement agencies. Main current activity in the Netherlands, Belgium, Italy.

Managing Director

Berrnell Food BV

2005-6 - 2013-12 · 8 yrs 7 mos

Groningen

Setting up the company, introducing Sporteff products in the Netherlands, Scandinavia and the UK. Also acquiring investment capital in order to increase our marketing power and introduce new, healthy products. In 2008 we acquired an existing health food company in order to broaden our client group and secure cash flow.

Business Development Director

Innosource

2010-1 - 2013-4 · 3 yrs 4 mos

Groningen

Innosource was a startup company. We provided testing facilities in which FMCG producers could test their products before launching them. This means we studied behaviour, not intentions. Further we supported market introductions of new products.